Exploring erythroid cell transcriptomics to understand regulation of fetal hemoglobin expression for advanced sickle cell disease treatment
Human Molecular Genetics · 2026
DOI: 10.1093/hmg/ddaf179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2026. Verfasst von Siana Nkya und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Muhimbili University of Health and Allied Sciences, United Nations Road, Upanga West District, P.O.…. Hauptthemen laut MEDLINE: Fetal Hemoglobin, Anemia, Sickle Cell, Transcriptome, Erythroid Cells. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Fogarty International Center of the National Institutes of Health.
Abstract (Originalsprache)
Fetal hemoglobin (HbF) modulates the clinical severity of sickle cell disease (SCD) by inhibiting the polymerization of sickle hemoglobin. Elevated HbF levels are associated with milder disease phenotypes, fewer Vaso-occlusive crises, and reduced organ damage. Understanding the molecular regulation of HbF expression is critical for the development of new therapeutic strategies, including pharmacologic agents and gene-based interventions aimed at ameliorating the course of SCD. We investigated transcriptomic expression in erythroid cells during the transition from the neonatal period to early childhood to identify genes associated with HbF regulation. Reticulocyte transcriptomes were compared between samples obtained at birth (cord blood), when HbF levels ranged from 72.6% to 90%, and at 18 months of age (whole blood), when HbF levels declined to 5.9%–10.3%. Reticulocytes were enriched, RNA extracted, and high-throughput RNA sequencing was performed, followed by differential gene expression and network analyses. Analysis of 20 346 genes revealed 1245 differentially expressed genes, of which 631 genes were upregulated in cord blood reticulocytes. The differentially expressed genes were significantly enriched in pathways related to cell signaling, proliferation, differentiation, metabolism, immune functionality, and erythropoiesis. Developmental shifts in the erythroid transcriptome uncover key biological processes that may regulate HbF expression. These findings offer a valuable panel of candidate genes for future functional studies and highlight new potential molecular targets for therapeutic modulation of HbF in sickle cell disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Muhimbili University of Health and Allied Sciences, United Nations Road, Upanga West District, P.O. Box 65001, Dar es Salaam, Tanzania.
- Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, United Nations Road, Upanga West District, P.O. Box 65001, Dar es Salaam, Tanzania.
- Tanzania Human Genetics Organization, Haile Selassie Road, Oysterbay District, P.O. Box 13591, Dar es Salaam, Tanzania.
- Sickle Cell Program, Muhimbili University of Health and Allied Sciences, United Nations Road, Upanga West District, P.O. Box 65001, Dar es Salaam, Tanzania.
- Central Pathology Laboratory, Muhimbili National Hospital, United Nations Road, Upanga West District, P.O. Box 65096, Dar es Salaam, Tanzania.
- Department of Paediatrics, Mnazi Mmoja Hospital, Kaunda Road, Stone Town, P.O. Box 1121, Zanzibar, Tanzania.
ORCID-Profile: Siana Nkya, Collin Nzunda, Emile R Chimusa
Förderung
- Fogarty International Center of the National Institutes of Health
Zitieren
APA
Nkya, S., Nzunda, C., Kaywanga, F., Karim, S., Solomon, D., Saukiwa, E., Christopher, H., Ngowi, D., Johansen, J., Urio, F., Mgaya, J., Chamba, C., Hashim, F., Ambrose, E. E., Acquah, S. O., Chimusa, E. R., & Makani, J. (2026). Exploring erythroid cell transcriptomics to understand regulation of fetal hemoglobin expression for advanced sickle cell disease treatment. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf179
Vancouver
Nkya S, Nzunda C, Kaywanga F, Karim S, Solomon D, Saukiwa E, et al. Exploring erythroid cell transcriptomics to understand regulation of fetal hemoglobin expression for advanced sickle cell disease treatment. Human Molecular Genetics. 2026. doi:10.1093/hmg/ddaf179
BibTeX
@article{Nkya2026,
author = {Nkya, Siana and Nzunda, Collin and Kaywanga, Frida and Karim, Salmaan and Solomon, David and Saukiwa, Emmanuel and Christopher, Heavenlight and Ngowi, Doreen and Johansen, Julieth and Urio, Florence and Mgaya, Josephine and Chamba, Clara and Hashim, Fadya and Ambrose, Emmanuela E and Acquah, Solomon Ofori and Chimusa, Emile R and Makani, Julie},
title = {Exploring erythroid cell transcriptomics to understand regulation of fetal hemoglobin expression for advanced sickle cell disease treatment},
journal = {Human Molecular Genetics},
year = {2026},
doi = {10.1093/hmg/ddaf179}
}
EUVIMED